"Integrase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds which inhibit or antagonize biosynthesis or actions of integrase.
| Descriptor ID |
D019429
|
| MeSH Number(s) |
D27.505.519.389.375
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Integrase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Integrase Inhibitors".
This graph shows the total number of publications written about "Integrase Inhibitors" by people in this website by year, and whether "Integrase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 4 | 1 | 5 |
| 2018 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Integrase Inhibitors" by people in Profiles.
-
Editorial - Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment. Eur Rev Med Pharmacol Sci. 2020 11; 24(22):11982-11984.
-
First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2). Clin Infect Dis. 2018 09 28; 67(8):1161-1167.
-
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA). BMC Infect Dis. 2018 07 31; 18(1):357.
-
Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants. AIDS Behav. 2018 04; 22(4):1209-1216.
-
Treatment with integrase inhibitor suggests a new interpretation of HIV RNA decay curves that reveals a subset of cells with slow integration. PLoS Pathog. 2017 Jul; 13(7):e1006478.
-
Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection. J Antimicrob Chemother. 2017 05 01; 72(5):1546-1547.
-
Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection-authors' response. J Antimicrob Chemother. 2017 05 01; 72(5):1547-1548.
-
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study. J Hypertens. 2017 02; 35(2):409-416.
-
Latest advances in the efficacy, tolerability, and monotherapy of integrase inhibitors. Biosci Trends. 2017; 11(4):490-495.